Comparison of 22-gauge and 19-gauge Aspiration Needle During EBUS-TBNA
Launched by UNIVERSITY HOSPITAL, ESSEN · Jun 22, 2016
Trial Information
Current as of September 30, 2025
Completed
Keywords
ClinConnect Summary
Investigators intend to compare the 19-gauge needle and the 22-gauge-needle during EBUS-TBNA performed in rigid bronchoscopy for patients with probable lung cancer diagnosis and enlarged mediastinal lymph nodes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female patients aged over 18
- • Patients signed written informed consent
- • Mediastinal or hilar enlarged lymph nodes (\>10mm) in short axis radiological or clinical findings likely for lung cancer
- Exclusion Criteria:
- • Severe impairment of any organs, with do not enable anaesthesia
- • Quick \<80%, INR \>1,5, thrombocytes \<50/nl or PTT\>120sec
- • Other clinically relevant medical or psychological diseases, which affect the patients judgement or ability to participate in this study.
- • Insufficient language ability (spoken and written German)
About University Hospital, Essen
The University Hospital Essen is a leading academic medical center dedicated to advancing healthcare through innovative research and comprehensive clinical services. As a prominent sponsor of clinical trials, the hospital leverages its extensive expertise in various medical disciplines to facilitate cutting-edge studies aimed at improving patient outcomes. With a commitment to scientific excellence and patient safety, the University Hospital Essen collaborates with a network of researchers and healthcare professionals to explore new therapies and treatment modalities, contributing significantly to the field of medicine and enhancing the overall quality of care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zürich, Switzerland
Essen, Nrw, Germany
Patients applied
Trial Officials
Kaid Darwiche, PD Dr. med.
Study Director
supervising doctor
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials